Acute Pain
“An unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage. Acute pain is of recent onset and limited duration. It usually has an identifiable temporal and causal relationship to injury or disease.”
— International Association for the Study of Pain (IASP)
Key characteristics of acute pain:
- Limited duration (typically lasting less than 3–6 months)
- Clear cause (usually related to tissue damage, surgery, trauma, or acute illness)
- Serves a biological warning function
- Generally resolves as healing occurs
- Physiological responses may include increased heart rate, blood pressure, respiratory rate, and stress hormone levels
Acute Pain Management in Primary Care
Leading international guidelines agree that acute pain should be treated with a multimodal, individualized approach emphasizing non-opioid and non-pharmacologic interventions as first-line. Opioids should be used only when absolutely necessary, at the lowest effective dose and shortest duration. Patient education, functional restoration, and shared decision-making are core principles. Early reassessment and avoidance of over medicalization are key to preventing chronic pain and unnecessary risk.
Consensus Recommendations
- Use NSAIDs or acetaminophen as first-line treatments for most acute pain types.
- Topical NSAIDs are preferred for localized musculoskeletal injuries.
- Avoid routine opioid prescribing; consider only for severe, refractory cases.
- Limit opioid use to ≤3–7 days at the lowest effective dose.
- Incorporate non-drug modalities, such as heat, ice, physical activity, and TENS.
- Provide pain education, set functional goals, and engage patients in self-management.
- Reassess pain and function regularly; adjust treatment based on progress.
- Use PDMP and risk screening tools when prescribing opioids.
- Avoid imaging and overtreatment unless red flags are present.
This 2020 clinical guideline from the American College of Physicians (ACP) and American Academy of Family Physicians (AAFP) addresses acute musculoskeletal pain (e.g., sprains, strains, contusions) lasting under four weeks in outpatient settings. Based on a robust network meta-analysis of 207 trials involving 32,959 adults, it evaluates both non-pharmacologic and pharmacologic strategies, emphasizing benefit–harm balance and patient preferences. It’s uniquely valuable for primary care providers treating non-low-back acute pain.
Guideline Summary:
Topical NSAIDs are the first-line recommendation, with oral NSAIDs and acetaminophen as second-line options. Opioids are not recommended due to limited benefit and higher risk. Adjunct therapies such as TENS and acupressure may offer short-term relief.
Recommended Interventions:
- Topical NSAIDs for short-term relief
- Oral NSAIDs or acetaminophen (conditional use)
- Acupressure and TENS as adjuncts
- Avoid opioids for initial management
- Prioritize functional improvement and patient education
Reference: Qaseem A, McLean RM, O’Gurek D, et al. Nonpharmacologic and Pharmacologic Management of Acute Pain From Non–Low Back, Musculoskeletal Injuries in Adults. Ann Intern Med. 2020;173(9):739–748.
This updated CDC guideline is a foundational resource for managing acute, subacute, and chronic pain in outpatient settings. It balances the need for pain relief with the importance of minimizing opioid-related harms. Emphasizing flexibility and patient-centered care, it promotes individualized treatment while discouraging routine opioid use for most acute pain scenarios. The guideline is especially useful for primary care clinicians managing post-injury, post-procedure, or musculoskeletal pain in opioid-naïve patients.
Guideline Summary:
The CDC recommends nonopioid treatments as first-line for most forms of acute pain and suggests prescribing opioids only when benefits clearly outweigh risks. It stresses short durations (typically ≤3–7 days), the lowest effective doses, and regular reassessment. Tools are provided to support safe initiation, monitoring, and tapering, along with guidance on co-prescribing naloxone and using the PDMP.
Recommended Interventions:
- NSAIDs and acetaminophen for mild to moderate pain
- Non-drug approaches (e.g., physical therapy, ice/heat, CBT)
- Prescription Drug Monitoring Program (PDMP) checks
- Naloxone co-prescribing for high-risk patients
- Reassessment within 1–4 weeks if opioids are used
Reference: Centers for Disease Control and Prevention. Clinical Practice Guideline for Prescribing Opioids for Pain — United States, 2022.
Though primarily a chronic pain guideline, the VA/DoD 2022 update includes detailed strategies for managing acute pain, especially in patients with complex needs. It provides a structured, multidisciplinary approach that is useful in both civilian and federal systems. It emphasizes whole-person care, promoting safer opioid use and effective nonpharmacologic treatment planning—principles that can be directly applied to acute pain scenarios in primary care.
Guideline Summary:
The guideline discourages initiating opioids for new acute pain episodes unless absolutely necessary. It emphasizes treating the whole person, accounting for mental health, functional goals, and risk factors for opioid misuse. Key interventions include education, shared decision-making, and use of behavioral and rehabilitative therapies prior to or alongside medications.
Recommended Interventions
- CBT, ACT, and other evidence-based psychotherapies
- Exercise and individualized physical therapy
- Multidisciplinary rehabilitation teams
- Spinal manipulation, yoga, acupuncture
- Relaxation training and biofeedback
- Patient goal-setting and functional recovery planning
Reference: VA/DoD Clinical Practice Guideline for Opioid Therapy for Chronic Pain. Version 4.0 – 2022.
Link: VA/DoD Clinical Practice Guideline for the use of Opioids in the Management of Chronic Pain
The European Pain Federation’s 2023 position paper offers a global, evidence-based framework for acute pain management across care settings. It promotes individualized, multimodal pain control and the minimization of opioid use. While not a formal guideline, it is an authoritative consensus statement based on current scientific evidence and clinical best practices, making it ideal for primary care clinicians worldwide.
Guideline Summary:
EFIC emphasizes treating acute pain as a biopsychosocial phenomenon. The position paper supports multimodal combinations—NSAIDs, acetaminophen, topical agents, and physical methods—while discouraging long-term opioid prescribing. It also promotes early functional activity and patient education to prevent chronicity.
Recommended Interventions:
- Combination of NSAIDs and acetaminophen
- Topical analgesics (e.g., lidocaine, diclofenac)
- Ice, rest, and graded return to activity
- Patient education on expected pain course
- Avoiding overmedicalization and opioid default prescribing
Reference: European Pain Federation EFIC. Position Paper on Multimodal Management of Acute Pain. 2023.
Developed by the Faculty of Pain Medicine of the Australian and New Zealand College of Anaesthetists, this is one of the most detailed and rigorously evidence-graded resources on acute pain management available globally. It provides practical, condition-specific guidance relevant across surgical, musculoskeletal, and trauma-related pain, and supports a multidisciplinary, multimodal treatment model.
Guideline Summary:
The ANZCA guide promotes structured assessment, tailored pain plans, and layered use of analgesics. It evaluates the evidence behind both pharmacologic and nonpharmacologic options, including acupuncture, TENS, psychological interventions, and patient education. It also includes pediatric and vulnerable population considerations.
Recommended Interventions:
- NSAIDs, acetaminophen, and weak opioids
- Topical and regional analgesia
- Psychological support and self-management
- Multimodal therapy to reduce opioid reliance
- Clinical pathways for post-injury and post-surgical pain
Reference: ANZCA Faculty of Pain Medicine. Acute Pain Management: Scientific Evidence. 5th ed. 2020.
Link: Acute Pain Management: Scientific Evidence 5th edition (2020)